Skip to main content

Programme Sponsored sessions

Friday April 12th - GMT Time zone

12:15 - 13:45
Auditorium A
Viatris Sponsored Lunch Satellite Symposium - Early Intervention in Osteoarthritis Care: Assessment and Treatment Chairperson : Hannah Moir
  • Welcome and Introduction Hannah Moir
  • Early Detection of Osteoarthritis: A Specific Questionnaire for Clinical Assessment of Knee OA Alberto Migliore
  • Exploring SYSADOAs in the Management of Osteoarthritis Nicholas R. Fuggle
  • Balance Between Effectiveness and Safety When Choosing NSAIDs for Osteoarthritis Treatment Ernest Choy
  • Q&A All
12:15 - 13:45
Auditorium B
Amgen Sponsored Lunch Satellite Symposium - Denosumab: Past, Present and Future – a discussion Chairperson : John A. Kanis
  • Lessons from the past: what we’ve learned about efficacy and safety of RANKL inhibitors Serge Ferrari
  • Present clinical experience: results from RWE and treatment landscape Bente Langdahl
  • New Osteoporosis guidelines: tailoring treatment according to patient profile – future approach Eugene V. McCloskey
14:00 - 15:00
Auditorium B
  • Welcome
  • Practicalities to setting up an FLS: Why, What and How
  • Becoming effective in modern practice: Why, What and How
  • Applying learnings to overcome challenges: Why, What and How
  • Final thoughts
17:00 - 18:30
Auditorium A
UCB Sponsored Satellite Symposium - Closing the treatment gap with romosozumab first: evidence from the real world Chairperson : Richard Keen
  • Welcome and introduction Richard Keen
  • Are we doing enough for our very high fracture risk patients? Richard Keen
  • Leave no patient behind: Identifying all eligible patients Bente Langdahl
  • Tales from the clinic: Real-world evidence of romosozumab Serge Ferrari
  • The small wins: Driving change in the clinic Carmelinda Ruggiero
  • Q&A / discussion All
  • Conclusions and closing remarks Richard Keen

Saturday April 13th - GMT Time zone

12:15 - 13:45
Auditorium A
Theramex Sponsored Lunch Satellite Symposium - Abaloparatide – managing postmenopausal osteoporosis with bone building and sequential therapy Chairperson : Jean-Yves Reginster
  • Welcome and Introduction Jean-Yves Reginster
  • Outcomes of the ACTIVE study: a pivotal trial highlighting the efficacy and tolerability of abaloparatide Nicholas Harvey
  • Optimising sequential therapy in postmenopausal osteoporosis with abaloparatide Maria Luisa Brandi
  • Abaloparatide - a review of the real-world evidence Eugene V. McCloskey
  • Questions and Answers All
12:15 - 13:45
Auditorium B
Alexion Sponsored Lunch Satellite Symposium - Evolving Perspectives in Adult Patients With Paediatric-onset Hypophosphatasia: From Diagnosis to Effective Management Chairperson : Maria Luisa Brandi
  • Welcome, Introductions Maria Luisa Brandi
  • Overcoming the Diagnostic Challenge in HPP Maria Luisa Brandi
  • Integrative Strategies in HPP Management Lothar Seefried
  • Bringing Adult Patients With Paediatric-onset HPP into the Spotlight: Case Studies Aliya Khan
  • Questions and Answers All
14:00 - 15:00
Auditorium B
IBSA Sponsored Educational Lecture - Osteoarthritis: what the guidelines and the clinical practice suggest
  • Update on pharmaceutical-grade Chondroitin Sulfate – from ESCEO algorithm to clinical data Jean-Yves Reginster
  • Enhancing Joint Care: Integrating Ultrasound Guidance and Advanced Hyaluronic Acid Formulations in Intra-Articular Injections Ezio Lanza
  • Q&A Session